ACET

ACET

USD

Adicet Bio Inc. Common Stock

$0.670+0.040 (6.349%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$0.630

Haut

$0.695

Bas

$0.630

Volume

0.00M

Fondamentaux de l'Entreprise

Capitalisation Boursière

55.4M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.84M

Bourse

NGM

Devise

USD

Intervalle sur 52 Semaines

Bas $0.447Actuel $0.670Haut $1.865

Actualités Connexes

BusinessWire

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards

Voir plus
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BusinessWire

Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the acceptance of an abstract

Voir plus
Adicet Bio Announces Oral Presentation Highlighting Preclinical ADI-270 Data at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
BusinessWire

Adicet Bio Appoints Michael Grissinger to the Board of Directors

--Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions-- Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company

Voir plus
Adicet Bio Appoints Michael Grissinger to the Board of Directors

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.